Inistón Mucosidad Sabor Menta

Guaifenesin, the active ingredient in Inistón Mucosidad Sabor Menta, is an expectorant presented as an oral formulation for oral use. It helps relieve chest congestion and facilitates the expectoration of mucus in patients with respiratory tract infections. Guaifenesin works by increasing the volume of respiratory secretions and reducing their viscosity, making it easier to clear the airways.

GNH USA supplies Inistón Mucosidad Sabor Menta as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Guaifenesin is an expectorant that acts on the respiratory tract to thin and loosen mucus, aiding its clearance in several conditions.

- Chest congestion: loosens thick mucus to improve airway clearance. - Acute bronchitis: reduces cough severity by facilitating mucus expectoration. - Upper respiratory tract infection: helps clear nasal and throat secretions. - Cough associated with the common cold: eases productive cough by thinning secretions.

Guaifenesin is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Nausea: mild stomach upset that may occur after oral intake. - Vomiting: occasional expulsion of stomach contents. - Headache: transient head discomfort. - Dizziness: brief sensation of light‑headedness. - Gastrointestinal discomfort: abdominal cramping or mild pain. - Rash: mild skin irritation or redness.

Serious or Rare Side Effects: - Allergic reaction: hives, swelling, or difficulty breathing. - Anaphylaxis: severe, life‑threatening hypersensitivity. - Angioedema: rapid swelling of face, lips, or tongue. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hematuria: presence of blood in urine. - Persistent vomiting: may lead to dehydration.

Before using Inistón Mucosidad Sabor Menta, consider the following safety measures.

- Pregnancy: consult a healthcare professional as safety data are limited. - Breastfeeding: use with caution; limited information on excretion in milk. - Renal impairment: dose adjustment may be required; monitor kidney function. - Age restrictions: not recommended for children under 4 years without medical advice. - Concomitant medications: review all current drugs to avoid potential interactions. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture and direct sunlight.

Guaifenesin may interact with certain medications; awareness helps prevent reduced efficacy or increased risk.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): concurrent use may increase the risk of hypertensive episodes. - Phenylpropanolamine-containing products: combined use can elevate blood pressure.

Moderate Interactions (Monitor Closely): - Codeine or other opioid antitussives: may diminish the expectorant effect of guaifenesin. - Antihypertensive agents: guaifenesin may modestly affect blood pressure control. - Diuretics: increased fluid loss could alter mucus hydration; monitor hydration status.